Dialectic cover image

15: D.A. Wallach - Serendipity & Systems

Dialectic

00:00

Investing in Uncertainty: The Evolution of Drug Development

This chapter examines the challenges and considerations of investing in emerging health technologies, especially in biotech sectors like gene editing. It contrasts established treatments with innovative therapies, focusing on the complexities of drug development and the significant breakthroughs in GLP-1 drugs.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner